Chilton Capital Management’s Zimmer Biomet ZBH Stock Holding History

Chilton Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-75	Closed	-$6.84K	–	613
2025 Q2	$6.84K	Buy	75 +20	+36%	+$1.93K	﹤0.01%	481
2025 Q1	$6.22K	Hold	55	–	–	﹤0.01%	479
2024 Q4	$5.81K	Buy	+55	New	+$5.9K	﹤0.01%	487
2024 Q1	–	Sell	-30	Closed	-$3.65K	–	668
2023 Q4	$3.65K	Hold	30	–	–	﹤0.01%	529
2023 Q3	$3.37K	Hold	30	–	–	﹤0.01%	475
2023 Q2	$4.37K	Hold	30	–	–	﹤0.01%	488
2023 Q1	$3.88K	Buy	+30	New	+$3.77K	﹤0.01%	502
2022 Q3	–	Sell	-30	Closed	-$3K	–	630
2022 Q2	$3K	Buy	+30	New	+$3.56K	﹤0.01%	581
2022 Q1	–	Sell	-31	Closed	-$4K	–	625
2021 Q4	$4K	Buy	+31	New	+$4.06K	﹤0.01%	574
2014 Q1	–	Sell	-138	Closed	-$12.5K	–	290
2013 Q4	$12.5K	Hold	138	–	–	﹤0.01%	315
2013 Q3	$11K	Hold	138	–	–	﹤0.01%	325
2013 Q2	$10K	Buy	+138	New	+$10.3K	﹤0.01%	335

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Chilton Capital Management's ZBH Position: Q3 2025 in Review

Chilton Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 75 shares — an estimated $6.84K sold.

Chilton Capital Management first reported a position in ZBH in Q2 2013 and held it in 12 quarters. The position peaked at $12.5K in Q4 2013. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

Chilton Capital Management reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
Chilton Capital Management sold 75 Zimmer Biomet shares in Q3 2025, an estimated $6.84K.
Chilton Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 12 quarters.
Chilton Capital Management's Zimmer Biomet position peaked at $12.5K in Q4 2013.
966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Chilton Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.